Companies criticised after admitting advertising breaches
Two pharmaceutical companies have recently been criticised for breaking the industry's advertising rules after reporting themselves for investigation.
Eli Lilly & Company Ltd reported, to the Association of the British
Pharmaceutical Industry’s disciplinary Prescription
Medicines Code of Practice Authority, that a company representative had taken part in
a broadcast radio competition and had made claims for Cialis (tadalafil)
in what she had thought to be an off-air conversation. The conversation
had subsequently been broadcast in full.
The PMCPA ruled that the representative had failed to maintain a high
standard of ethical conduct and had promoted a prescription medicine
to the public.
Janssen-Cilag was also ruled to have breached the ABPI advertising code
after it reported that pages printed from a website contained a promotional
claim. The claim was only visible when pages were printed and was not
displayed on-screen. The website had been designed for on-screen viewing
only and users had not been expected to make print-outs. |
The
Pharmaceutical Journal
Acrobat
Reader